These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28760534)

  • 1. An analysis of factors related to the effect of sublingual immunotherapy on Japanese cedar pollen induced allergic rhinitis.
    Yonekura S; Okamoto Y; Sakurai D; Okubo K; Gotoh M; Kaneko S; Konno A
    Allergol Int; 2018 Apr; 67(2):201-208. PubMed ID: 28760534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
    Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A
    Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
    Sakurai T; Yonekura S; Iinuma T; Sakurai D; Morimoto Y; Kaneko S; Okamoto Y
    Int Arch Allergy Immunol; 2018; 177(3):245-254. PubMed ID: 30021201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.
    Gotoh M; Yonekura S; Imai T; Kaneko S; Horikawa E; Konno A; Okamoto Y; Okubo K
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1287-1297.e8. PubMed ID: 30537561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy for allergic rhinitis: subjective versus objective tools to evaluate its success.
    Sakurai D; Yonekura S; Iinuma T; Sakurai T; Morimoto Y; Mita Y; Arai T; Suzuki S; Okuma Y; Kaneko S; Okamoto Y
    Rhinology; 2016 Sep; 54(3):221-30. PubMed ID: 27107025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.
    Yamanaka K; Shah SA; Sakaida H; Yamagiwa A; Masuda S; Mizutani H; Takeuchi K
    Allergol Int; 2015 Jan; 64(1):54-9. PubMed ID: 25605528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons.
    Yonekura S; Gotoh M; Kaneko S; Kanazawa K; Takeuji Y; Okubo K; Okamoto Y
    Allergol Int; 2019 Oct; 68(4):494-505. PubMed ID: 31257168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
    Yuta A; Miyamoto Y; Ogihara H; Hattori R; Okubo K
    Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy.
    Otsuka K; Otsuka H; Matsune S; Okubo K
    Immun Inflamm Dis; 2020 Sep; 8(3):333-341. PubMed ID: 32468704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen.
    Ueda S; Ito J; Harada N; Harada S; Sasano H; Sandhu Y; Tanabe Y; Abe S; Shiota S; Kodama Y; Nagaoka T; Makino F; Chiba A; Akiba H; Atsuta R; Miyake S; Takahashi K
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A MULTICENTER CLINICAL SURVEY ABOUT THE PREVALENCE OF JAPANESE CYPRESS POLLINOSIS AND THE EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH JAPANESE CEDAR POLLEN EXTRACT DURING JAPANESE CYPRESS POLLEN DISPERSAL PERIOD].
    Oka A; Yuta A; Okawa Y; Masuno S; Tsunoda T; Takahara E; Terada A; Kanai K; Nagakura H; Mimura H; Arao H; Ueyama S; Ueyama A; Tokuda R; Bamba H; Nakazato H; Nakazato M; Amesara R; Nakai S; Araki S; Sakaida M; Tokuriki M; Hama T; Chiba M; Ikeda H; Togawa A; Tsuzuki H; Hyo Y; Niitsu S; Ohkawa C; Nakamoto S; Takeo T; Kumanomidou H; Kanai K; Kitamura H; Sugiura R; Okano M
    Arerugi; 2023; 72(9):1138-1146. PubMed ID: 37967960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
    Mitobe Y; Yokomoto Y; Ohashi-Doi K
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis.
    Hamada S; Kobayashi Y; Sakamoto D; Shimamura A; Kuroda K; Kawachi R; Kanda A; Asako M; Gotoh M; Okubo K; Tomoda K; Iwai H
    Auris Nasus Larynx; 2021 Aug; 48(4):646-652. PubMed ID: 33526319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Japanese cedar-specific sublingual immunotherapy on allergen-specific TH2 cell counts in blood.
    Nomura T; Suzuki M; Yokota M; Nakamura Y; Ozeki K; Ito Y; Tsuge I; Saitoh S
    Ann Allergy Asthma Immunol; 2016 Jul; 117(1):72-78.e4. PubMed ID: 27156747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial.
    Nomura Y; Okubo K; Nakamura T; Sawaki S; Kitagou H; Idei N; Kaneko S; Kobayashi S; Tanaka Y; Okamoto Y
    Allergol Int; 2021 Jan; 70(1):96-104. PubMed ID: 32653209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE THIRD TREATED YEAR WITH JAPANESE CEDAR POLLINOSIS IN 2017].
    Yuta A; Ogawa Y; Suzuki Y; Ogihara H; Ohta N; Kozaki H; Shimizu T
    Arerugi; 2017; 66(9):1172-1180. PubMed ID: 29129888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of biomarker sets for predicting the efficacy of sublingual immunotherapy against pollen-induced allergic rhinitis.
    Gotoh M; Kaminuma O; Nakaya A; Katayama K; Motoi Y; Watanabe N; Saeki M; Nishimura T; Kitamura N; Yamaoka K; Okubo K; Hiroi T
    Int Immunol; 2017 Jun; 29(6):291-300. PubMed ID: 28575522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ENHANCED CLINICAL EFFECTS OF CEDARCURE
    Yuta A; Ogawa Y; Murao T; Kozaki H; Shimizu T
    Arerugi; 2022; 71(9):1122-1128. PubMed ID: 36372423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH CEDAR POLLEN IN A YEAR OF MASSIVE CEDAR POLLEN DISPERSAL AND ITS EFFECT ON JAPANESE CYPRESS POLLINOSIS].
    Yuta A; Ogawa Y; Kozaki H; Shimizu T
    Arerugi; 2023; 72(10):1230-1239. PubMed ID: 38092399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.